Opiant Pharmaceuticals Inc  

(Public, OTCMKTS:OPNT)   Watch this stock  
Find more results for NASDAQ:OPNT
+0.02 (0.25%)
Delayed:   10:52AM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 7.98 - 8.01
52 week 6.00 - 14.00
Open 7.98
Vol / Avg. 4,259.00/3,644.00
Mkt cap 16.48M
P/E     -
Div/yield     -
EPS -5.22
Shares 1.99M
Beta 0.40
Inst. own     -
Jun 9, 2016
Q3 2016 Opiant Pharmaceuticals Inc Earnings Release

Key stats and ratios

Q2 (Apr '16) 2015
Net profit margin 15.97% -454.06%
Operating margin 15.81% -445.13%
EBITD margin - -445.04%
Return on average assets 88.13% -1785.22%
Return on average equity - -
Employees 3 -
CDP Score - -


401 Wilshire Blvd Fl 12
SANTA MONICA, CA 90401-1456
United States - Map
+1-424-2524756 (Phone)
+1-917-3222105 (Fax)

Website links


Opiant Pharmaceuticals, Inc., formerly Lightlake Therapeutics, Inc., is a specialty pharmaceutical company. The Company is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. The Company focuses on developing a treatment for reverse opioid overdoses, a treatment for overweight and obese patients with binge eating disorder, and a treatment for cocaine use disorder (CocUD). The Company is developing a treatment for reversing opioid overdoses in collaboration with the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH). The Company is also developing a treatment for binge eating disorder derived from the Sinclair Method. The Company also has completed a Phase II clinical trial to treat binge eating disorder. The Company's product, NARCAN Nasal Spray, contains naloxone hydrochloride. NARCAN Nasal Spray is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.

Officers and directors

Michael J. Sinclair Executive Chairman of the Board
Age: 73
Roger Crystal President, Chief Executive Officer, Director
Age: 38
Kevin A. Pollack Chief Financial Officer, Treasurer, Secretary, Director
Age: 44
Arvind Agrawal Executive Vice President - Medical Affairs
Ann L. MacDougall Director
Gabrielle Silver Director
Age: 42
Geoffrey Wolf Director
Age: 61